Literature DB >> 14574682

Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells.

Alessandro Cellerino1, Blanca Arango-González, Germán Pinzón-Duarte, Konrad Kohler.   

Abstract

Brain-derived neurotrophic-factor (BDNF) is expressed in the retina and controls the development of subtypes of amacrine cells. In the present study we investigated the effects of BDNF on amacrine cells expressing vasoactive intestinal polypeptide (VIP). Rats received three intraocular injections of BDNF on postnatal days (P) 16, 18, and 20. The animals were sacrificed on P22, P40, P60, P80, and P120, and VIP expression in their retinas was detected by immunohistochemistry (P22, P40) and by radioimmunoassay (RIA; P22, P40, P60, P80, P120) to assess the time course of BDNF effects on VIP. A significant increase in the density of VIP-positive amacrine cells was detected in BDNF-treated retinas, and VIP concentration was up-regulated by 150% both at P22 and at P40 with respect to untreated controls. VIP concentration then slowly declined in the treated retinas over a period of 3 months; however, a statistically significant increase of 50% was still detectable on P120. The impact of endogenous BDNF on the regulation of VIP expression in the retina was analyzed in mice homozygous for a targeted deletion of the BDNF gene locus (bdnf-/-). VIP immunohistochemistry revealed a marked reduction of VIP-positive amacrine cells and of VIP-immunopositive processes in the inner plexiform layer of the BDNF knockout mice. Mice lacking BDNF expressed only 5% of the VIP protein in their retinas compared with the retinas of wild-type mice as measured by RIA. Our data show that BDNF is a major regulator of VIP expression in retinal amacrine cells and exerts long-lasting effects on VIP content. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574682     DOI: 10.1002/cne.10908

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

Review 1.  Neurotrophins in the Brain: Interaction With Alcohol Exposure During Development.

Authors:  K E Boschen; A Y Klintsova
Journal:  Vitam Horm       Date:  2016-11-29       Impact factor: 3.421

2.  TrkB/BDNF signaling regulates photoreceptor progenitor cell fate decisions.

Authors:  Brian A Turner; Janet Sparrow; Bolin Cai; Julie Monroe; Takashi Mikawa; Barbara L Hempstead
Journal:  Dev Biol       Date:  2006-08-14       Impact factor: 3.582

3.  Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision.

Authors:  Ute Mathis; Frank Schaeffel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

Review 4.  Neuropeptides and diabetic retinopathy.

Authors:  Robert Gábriel
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

5.  The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.

Authors:  T Jehle; C Dimitriu; S Auer; R Knoth; M Vidal-Sanz; I Gozes; W A Lagrèze
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-15       Impact factor: 3.117

6.  Setting the pace for retinal development: environmental enrichment acts through insulin-like growth factor 1 and brain-derived neurotrophic factor.

Authors:  Silvia Landi; Francesca Ciucci; Lamberto Maffei; Nicoletta Berardi; Maria Cristina Cenni
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

Review 7.  Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice.

Authors:  Etelka Pöstyéni; Alma Ganczer; Andrea Kovács-Valasek; Robert Gabriel
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

8.  Injury-associated PACAP expression in rat sensory and motor neurons is induced by endogenous BDNF.

Authors:  Lina M E Pettersson; Nicole M Geremia; Zhengxin Ying; Valerie M K Verge
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.